As of 30 June FY17 underlying (cash) EBITDA was $139 m. Divide by 950.3 m units issued = 14.6c per unit. P/E at the current share price of 67c = 4.6x. Bargain.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025